ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)


Volume 13, 12 Issues, 2016


Download PDF Flyer




Current Alzheimer Research

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 34th of 192 in Clinical Neurology
  • 69th of 252 in Neurosciences

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Prof. Debomoy K. Lahiri
Department of Psychiatry, Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.889
5 - Year: 3.933

Upcoming Articles (E-Pub Abstracts ahead of Print)

Intracellular Aβ and its pathological role in Alzheimer’s disease: Lessons from cell and animal models


Lina Ji, Xi Zhao, Weijie Lu, Qing Zhang and Zichun Hua.


View Abstract


The TT allele of rs405509 synergizes with APOE ε4 in the impairment of cognition and its underlying default mode network in non-demented elderly


Chao Ma, Yangjun Zhang, Xin Li, Yaojing Chen, Junying Zhang, Zhen Liu, Kewei Chen and Zhanjun Zhang.


View Abstract


Glial cells – the key elements of Alzheimer´s disease


David Dzamba, Lenka Harantova, Olena Butenko and Miroslava Anderova.


View Abstract


Cerebrospinal fluid proNGF: A putative biomarker for early Alzheimer’s disease


Scott E. Counts, Bin He, John G. Prout, Bernadeta Michalski, Lucia Farotti, Margaret Fahnestock and Elliott J Mufson.


View Abstract


Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer’s Disease


Sofya Ziyatdinova, Annica Rönnbäck, Kestutis Gurevicius, Diana Miszczuk, Caroline Graf, Bengt Winblad, Asla Pitkänen and Heikki Tanila.


View Abstract


Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer’s Disease in the Transgenic CRND8 Mice


Zhi Tang, Liangfeng Liu, Yongle Li, Jiyang Dong, Min Li, Jiandong Huang, Shuhai Lin and Zongwei Cai.


View Abstract


METABOLOMIC-DRIVEN ELUCIDATION OF SERUM DISTURBANCES ASSOCIATED WITH ALZHEIMER´S DISEASE AND MILD COGNITIVE IMPAIRMENT


Raúl González-Domínguez, Francisco Javier Rupérez, Tamara García-Barrera, Coral Barbas and José Luis Gómez-Ariza.


View Abstract


Probabilistic cost-effectiveness analysis of vaccination for mild or moderate Alzheimer’s disease


Kuen Cheh Yang and Hsiu-Hsi Chen.


View Abstract


Early β-Amyloid-induced Synaptic Dysfunction Is Counteracted by Estrogen in Organotypic Hippocampal Cultures


Sara Merlo, Simona Federica Spampinato, Francisco Capani and Maria Angela Sortino.


View Abstract


Hippocampal subfield atrophies in converted and not-converted Mild Cognitive Impairments patients by a Markov random fields algorithm


Roberta Vasta, Antonio Augimeri, Antonio Cerasa, Salvatore Nigro, Vera Gramigna, Matteo Nonnis, Federico Rocca, Giancarlo Zito and Aldo Quattrone.


View Abstract


Evidence for mitochondrial UPR gene activation in familial and sporadic Alzheimer’s disease


John S. Beck, Elliott J. Mufson and Scott E Counts.


View Abstract


Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians


Zixuan Yang, Wei Wen, Jiyang Jiang, John D. Crawford, Simone Reppermund, Charlene Levitan, Melissa J. Slavin, Nicole A. Kochan, Robyn L. Richmond, Henry Brodaty, Julian N. Trollor and Perminder S Sachdev.


View Abstract


Defining the earliest pathological changes of Alzheimer’s disease


JC Vickers, A Woodhouse, CM Fernandez-Martos, MT Kirkcaldie, AJ Canty, GH McCormack and AE King.


View Abstract


The relationship between plasma Aβ levels, cognitive function and brain volumetrics: Sydney Memory and Ageing Study


A Poljak, JD Crawford, GA Smythe, H Brodaty, MJ Slavin, NA Kochan, JN Trollor, W Wen, KA Mather, AA Assareh, PC Ng and PS Sachdev.


View Abstract


Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer’s Disease: A Meta-Analysis


Jing Xu, Lei-Lei Xia, Ning Song, Sheng-Di Chen and Gang Wang.


View Abstract


Perspectives on the tertiary prevention strategy for Alzheimer’s disease


Xian-Le Bu, Shu-Sheng Jiao, Yan Lian and Yan-Jiang Wang.


View Abstract


Frontiers for the early diagnosis of AD by means of MRI brain imaging and Support Vector Machines


Christian Salvatore, Petronilla Battista and Isabella Castiglioni.


View Abstract


Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: a vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?


Ilaria Vanzuli, Andrea Rivera, José Julio Rodríguez Arellano and Arthur Butt.


View Abstract


Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease


Antonio Giuliano Zippo and Isabella Castiglioni.


View Abstract


A Statistical Projection of MRI Brain Images for the Detection of Alzheimer's Disease


F.J. Martinez-Murcia, J.M. Gorriz, J. Ramirez and A Ortiz.


View Abstract


Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD


Francesca Gallivanone, Pasquale Anthony Della Rosa and Isabella Castiglioni.


View Abstract


Combining feature extraction methods to assist the diagnosis of Alzheimer’s disease


F. Segovia, J. M. G'orriz, J. Ram'ırez, C. Phillips and for the Alzheimer's Disease Neuroimaging Initiative.


View Abstract


Cortical and subcortical changes in Alzheimer’s disease: a longitudinal and quantitative MRI study


Li Su, Andrew M. Blamire, Rosie Watson, Jiabao He, Benjamin Aribisala and John T O’Brien.


View Abstract


Brain local and regional neuroglial alterations in Alzheimer´s Disease: cell types, responses and implications.


Adolfo Toledano, María-Isabel Álvarez, Adolfo Toledano-Díaz, José-Joaquín Merino and José Julio Rodríguez.


View Abstract


Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease


Dmitry Lim, J.J Rodríguez-Arellano, Vladimir Parpura, Robert Zorec, Fares Zeidán-Chuliá, Armando A. Genazzani and Alexei Verkhratsky.


View Abstract


Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in Alzheimer,s disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?


José Joaquín Merino, Vilma Muñetón-Gómez, María-Isabel Alvárez and Adolfo Toledano-Díaz.


View Abstract


Eigenanatomy on fractional anisotropy imaging provides white matter anatomical features discriminating between Alzheimer’s Disease and Late Onset Bipolar Disorder


Ariadna Besga-Basterra, Darya Chyzhyk, Itxaso González-Ortega, Alexandre Savio, Borja Ayerdi, Jon Echeveste, Manuel Graña and Ana González-Pinto.


View Abstract


Untangling Alzheimer’s disease clinicoanatomical heterogeneity through selective network vulnerability – an effort to understand a complex disease


David Bergeron, Reda Bensaïdane and Robert Laforce Jr.


View Abstract


Microglia in Alzheimer's disease: the good, the bad and the ugly


Dario Tejera and Michael T Heneka.


View Abstract


Lymphocytes in Alzheimer’s disease pathology: Altered signaling pathways


Noemí Esteras, Carolina Alquézar, Ana de la Encarnación and Ángeles Martín-Requero.


View Abstract


Metabolic Control of Glia-Mediated Neuroinflammation


Mithilesh Kumar Jha, Dong Ho Park, Hyun Kook, In-Kyu Lee and Kyoungho Suk.


View Abstract


Rhein-huprine derivatives reduce cognitive impairment, synaptic failure and amyloid pathology in AβPPswe/PS-1 mice of different ages


FG Serrano, C Tapia-Rojas, FJ Carvajal, P Cisternas, E Viayna, Sola Irene, D Muñoz-Torrero and NC Inestrosa.


View Abstract View on PubMed


Prevalence of cognitive impairment and dementia in Malays – Epidemiology of Dementia in Singapore Study


S Hilal, CS Tan, S Xin, SM Amin, TY Wong, C Chen, N Venketasubramanian and MK Ikram.


View Abstract View on PubMed


The Role of α-Synuclein in Neurodegenerative Diseases: From Molecular Pathways in Disease to Therapeutic Approaches


Al- Mansoori KM, Hasan MY, Al- Hayani A and El- Agnaf OMA.


View Abstract


Bioavailability of 13-desmethyl spirolide C and improvement of Alzheimer disease markers in vivo observed by Proton magnetic resonance spectroscopy and immunoblotting analysis


E Alonso, P. Otero, C. Vale, A. Alfonso, A. Antelo, L. Giménez-Llort, L. Chabaud, C. Guillou and L M Botana.


View Abstract


Pro-inflammatory cytokines IL-1? and TNF-? are not associated with blood homocysteine concentration in Alzheimer's disease


L. Veryard, E. Jones, G. Weaving, E. Smith, L. Cheek, A. Wickramasinghe and N Tabet.


View Abstract


Natural Modulators of Amyloid-Beta Precursor Protein Processing


Zhang C and Tanzi RE.


View Abstract


Current advancements in Ab luminescent probes and inhibitors of Ab aggregation


C-H Leung, DS-H Chan, VP-Y Ma, K-H Leung and H-J Zhong.


View Abstract


Advertisement
Alzheimer’s 2016

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science